Drug intelligence / Profile preview

zihuangjing

Development stage: Preclinical
Modality: Drug Delivery Systems, Small Molecules
Administration: Oral

Overview

Zihuangjing is a tablet formulation used in China, primarily studied for its potential to alleviate cancer-related fatigue during chemotherapy. It appears to be based on traditional Chinese medicine principles and may contain herbal components, though the precise composition is not specified in the available literature. The mechanism of action has not been fully elucidated but is likely related to immunomodulatory or adaptogenic effects typical of certain traditional Chinese medicinal products[7]. There are no details indicating it targets a specific molecular pathway or receptor.

Brand names: Zihuangjing
Other names: Zihuangjing

Beyond the preview

Go deeper on zihuangjing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zihuangjing.

Explore the full profile